Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 018
mi
from
Little Rock, AR
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 018
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 012
mi
from
Cerritos, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 012
mi
from
Cerritos, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 010
mi
from
Costa Mesa, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 026
mi
from
Culver City, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 026
mi
from
Culver City, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 004
mi
from
Long Beach, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 004
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Oceanside, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 42
mi
from
Paramount, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 42
mi
from
Paramount, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 007
mi
from
San Diego, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 007
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 008
mi
from
Washington,
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 008
mi
from
Washington,
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 15
mi
from
Leesburg, FL
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 15
mi
from
Leesburg, FL
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Atlanta, GA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Chicago, IL
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Baltimore, MD
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 006
mi
from
Rockville, MD
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 006
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 001
mi
from
Flowood, MS
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 001
mi
from
Flowood, MS
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 022
mi
from
Creve Coeur, MO
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 022
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative site 026
mi
from
Dayton, OH
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative site 026
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 014
mi
from
Austin, TX
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 014
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 014
mi
from
Austin, TX
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 014
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Dallas, TX
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Houston, TX
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Houston, TX
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 009
mi
from
Orange, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 009
mi
from
Orange, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 008
mi
from
Cedarhurst, NY
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 008
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 1559
mi
from
Saint Louis, MO
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 1559
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 305
mi
from
Vijayawada,
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 305
mi
from
Vijayawada,
Click here to add this to my saved trials
Electronic Decision Support Systems for Smokers With Severe Mental Illness
Electronic Decision Support Systems for Smokers With Severe Mental Illness
Status: Enrolling
Updated:  12/31/1969
Thresholds Psychiatric Rehabilitation Center
mi
from
Chicago, IL
Electronic Decision Support Systems for Smokers With Severe Mental Illness
Electronic Decision Support Systems for Smokers With Severe Mental Illness
Status: Enrolling
Updated: 12/31/1969
Thresholds Psychiatric Rehabilitation Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Cerritos, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Cerritos, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Washington,
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Washington,
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Atlanta, GA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Overland Park, KA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Rockville, MD
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Philadelphia, PA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Charleston, SC
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Austin, TX
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Springdale, AR
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Springdale, AR
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
La Habra, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
La Habra, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Oakland, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oakland, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Oceanside, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Orange, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
San Diego, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Leesburg, FL
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Leesburg, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Creve Coeur, MO
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Burgas,
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Burgas,
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Fort Lauderdale, FL
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials